Separately, Haleon will also buy around £230 million worth of its shares from Pfizer at the price set in the share offering, ...

Following a similar move in March, Pfizer is offloading another tranche of Haleon shares. | Pfizer has sold 640 million ...

This came after GlaxoSmithKline Pharmaceuticals presented protocol amendment 03 dated 25 June 2024 protocol no. 209628.

Pfizer Inc. ($PFE) has sold its stake worth $3.26 billion in UK-based consumer healthcare company Haleon PLC ($GB:HLN). With ...

Pfizer has offloaded a £2.43billion stake in consumer health spin-out Haleon, which said it would buy back £230million of the ...

A Matlock youngster was presented with a prestigious award by Prince Harry this week in recognition of the exceptional care ...

A nurse from Cardiff who has been described as a "guardian angel" has been celebrated for the amazing work that she does at ...

Haleon was formed in 2019 by the merger of the consumer healthcare businesses of GSK and US rival Pfizer, but was spun out ...

Pfizer, a New York-based pharmaceuticals firm, sold 640 million Haleon shares at 380 pence per share in a placing run by Goldman Sachs International and BofA Securities as joint global coordinators.

Barclays cuts Smiths Group to 'equal weight' (overweight) - price target 1,825 (1,845) pence Morgan Stanley raises Carnival target to 1,250 (1,150) pence - 'underweight' ...

Toy firm Character on track despite shipping headwinds 08:54 , Graeme Evans Character Group, the ...

Pfizer has sold a stake in British consumer healthcare group Haleon worth about $3.26 billion, cutting its shareholding in ...